Clinical Trial Update: Phase II Combination Stem Cell Therapy for the Treatment of Severe Coronary Ischemia(CI) [Phase 2]

View source ↗

Summary

Phase II trial of a combination stem cell therapy for severe coronary ischemia has been suspended.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Coronary Atherosclerosis
• Ischemic Heart Disease

Drugs mentioned

• Stem cell therapy (stem cell)

Snippet

Sponsor: TCA Cellular Therapy | Conditions: Heart Disease, Blocked Arteries | Phase 2 | Status: SUSPENDED